NCT05175261View on ClinicalTrials.gov

Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRIIa

CompletedOBSERVATIONAL

Enrollment

764

Participants

Timeline

Start Date

January 20, 2022

Primary Completion Date

April 18, 2025

Study Completion Date

May 22, 2025

Conditions

STEMINSTEMI

Interventions

DIAGNOSTIC_TEST

Prolocor pFCG test

Perform pFCG test on patients admitted with myocardial infarction to assess prognosis

Trial Locations (1)

05401

University of Vermont, Burlington

All Listed Sponsors

lead

Prolocor, Inc

INDUSTRY